Breaking News, Collaborations & Alliances

SK Selects Patheon as CNS Partner

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Patheon has been selected by SK Life Science, Inc., the US-based subsidiary of Korean SK Holdings, as its development services partner for two Central Nervous System (CNS) drug candidates. Patheon will provide formulation and analytical development services as well as clinical supplies for one of the CNS candidates in advanced clinical studies. Patheon will also provide development and clinical materials manufacturing services for another CNS candidate in Phase I trials.     “We are ve...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters